Curis Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Lexington MA United States (2000)

Organization Overview

First Clinical Trial
2000
NCT00004487
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Curis, Inc.